COMT Gene and Breast Cancer Risk in Young Women
Author Information
Author(s): Bergman-Jungeström M, Wingren S
Primary Institution: Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health Sciences, University Hospital, Linköping, Sweden
Hypothesis
The low-activity allele, COMTMet, may be implicated in early onset breast cancer.
Conclusion
The study found no significant difference in the frequency of low-/high-activity alleles between breast cancer patients and healthy controls.
Supporting Evidence
- The study included 126 young breast cancer patients and 117 healthy controls.
- No significant association was found between the COMTMet genotype and breast cancer risk.
Takeaway
Researchers wanted to see if a specific gene variant could increase the risk of breast cancer in young women, but they found it didn't make a difference.
Methodology
A case-control study comparing 126 young breast cancer patients to 117 healthy female blood donors.
Limitations
The study only looked at a single genetic polymorphism and may not account for other factors influencing breast cancer risk.
Participant Demographics
Young women aged 36 years or younger.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website